LDLKX | LSCSX | LDLKX / LSCSX | |
Total Expense Ratio | 0.63 | 0.65 | 97% |
Annual Report Gross Expense Ratio | 0.63 | 0.77 | 82% |
Fund Existence | 10 years | 8 years | - |
Gain YTD | 3.785 | 3.203 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 42.8B | 629M | 6,804% |
Annual Yield % from dividends | 4.99 | 4.54 | 110% |
Returns for 1 year | 5.40 | 4.76 | 113% |
Returns for 3 years | 13.76 | 14.04 | 98% |
Returns for 5 years | 12.62 | 11.21 | 113% |
Returns for 10 years | 28.19 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
STEW | 18.09 | 0.09 | +0.50% |
SRH Total Return Fund | |||
IBTO | 24.42 | 0.06 | +0.25% |
iShares iBonds Dec 2033 Term Trsy ETF | |||
KLIP | 32.80 | 0.02 | +0.05% |
KraneShares KWEB Covered Call Strat ETF | |||
HELX | 29.28 | -0.20 | -0.69% |
Franklin Genomic Advancements ETF | |||
EUAD | 41.57 | -1.47 | -3.42% |
Select STOXX Europe Aerospace & Defense ETF |